Pushback to U.S. Health agencies grows over handling of COVID-19 vaccine boosters

In this March 26 file photo a member of the Philadelphia Fire Department prepares a dose of the Johnson & Johnson COVID-19 vaccine at a vaccination site setup in Philadelphia. (AP Photo/Matt Rourke, File)
Zachary Stieber The Epoch Times Pushback to two top U.S. health agencies is growing over how officials handled clearing and recommending COVID-19 vaccine boosters. The Food and Drug Administration last month authorized boosters of all three vaccines available in the United States for all adults. Soon after, the Centers for Disease Control and Prevention recommended that any American 18 or older should get a booster, regardless of prior infection or underlying health conditions. Then, earlier this month, regulators cleared a booster of Pfizer’s shot for 16- and 17-year-olds. The agencies did not convene their vaccine advisory panels before making the major decisions, stoking pushback. Philip Krause and Luciana Borio, two former top FDA officials, said in a recent op-e
Subscribe or log in to read the rest of this content.